We are live on ! Find out more
AXNX

Axonics, Inc. Common Stock

Delisted

AXNX was delisted on the 14th of November, 2024.

103 hedge funds and large institutions have $565M invested in Axonics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 42 increasing their positions, 10 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 10

203% more call options, than puts

Call options by funds: $3.38M | Put options by funds: $1.11M

147% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 15

116% more capital invested

Capital invested by funds: $261M → $565M (+$304M)

27% more funds holding

Funds holding: 81103 (+22)

Holders
103
Holders Change
+22
Holders Change %
+27.16%
% of All Funds
2.03%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
37
Increased
42
Reduced
10
Closed
15
Calls
$3.38M
Puts
$1.11M
Net Calls
+$2.26M
Net Calls Change
+$2.26M
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
1
Millennium Management
New York
$53.6M +$40.2M +1,682,598 +666%
RI
2
RTW Investments
New York
$44.1M +$1.36M +57,027 +4%
RG
3
Redmile Group
California
$42.5M +$17.2M +722,300 +89%
BlackRock
4
BlackRock
New York
$38.5M +$9.89M +414,353 +43%
CAM
5
Cormorant Asset Management
Massachusetts
$33.9M
RSCM
6
Rock Springs Capital Management
Maryland
$30.5M +$21.4M +897,500 +443%
DM
7
Deerfield Management
New York
$23.2M +$20M +837,945 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$21.8M +$5.21M +218,287 +38%
PCM
9
Peregrine Capital Management
Minnesota
$17M +$14.6M +613,521 New
PHS
10
PFM Health Sciences
California
$15.2M +$7.13M +298,565 +119%
SC
11
Samlyn Capital
New York
$14.4M +$12.4M +518,034 New
Citadel Advisors
12
Citadel Advisors
Florida
$13.5M -$737K -30,869 -6%
Thrivent Financial for Lutherans
13
Thrivent Financial for Lutherans
Minnesota
$13.5M +$6.91M +289,495 +146%
GPP
14
Great Point Partners
Connecticut
$12.9M +$11.1M +466,507 New
Balyasny Asset Management
15
Balyasny Asset Management
Illinois
$12.7M +$10.9M +458,042 New
BC
16
Blackcrane Capital
Washington
$12.5M +$10.8M +451,000 New
Fidelity Investments
17
Fidelity Investments
Massachusetts
$12.4M -$9.29M -389,306 -46%
JGC
18
J. Goldman & Co
New York
$11.2M +$7.94M +332,750 +473%
RPAM
19
Rhenman & Partners Asset Management
Sweden
$9.14M +$7.88M +330,000 New
PGM
20
Parian Global Management
New York
$9.04M +$6.89M +288,737 +770%
State Street
21
State Street
Massachusetts
$8.91M +$262K +10,972 +4%
Lord, Abbett & Co
22
Lord, Abbett & Co
New Jersey
$8.56M +$37.6K +1,576 +0.5%
Point72 Asset Management
23
Point72 Asset Management
Connecticut
$8.01M +$6.9M +289,219 New
Geode Capital Management
24
Geode Capital Management
Massachusetts
$5.83M +$1.29M +53,951 +35%
APM
25
Avidity Partners Management
Texas
$5.76M +$4.96M +208,000 New

AXNX Hedge Fund Activity: Q4 2019 in Review

103 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q4 2019, worth a combined $565M — up 116% from $261M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new AXNX positions and 15 closed out — a net gain of 22 holders — while 42 added to existing stakes and 10 trimmed.

The largest buyer was Millennium Management, adding an estimated $40.2M. The largest seller was Fidelity Investments, cutting an estimated $9.29M.

  • 103 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q4 2019, up from 81 in Q3 2019.
  • Funds reported $565M of Axonics, Inc. Common Stock stock for Q4 2019, up 116% quarter-over-quarter.
  • 37 funds opened new Axonics, Inc. Common Stock positions in Q4 2019 and 15 closed out, a net change of +22 holders.
  • The largest Axonics, Inc. Common Stock buyer in Q4 2019 was Millennium Management, an estimated $40.2M added.
  • The largest Axonics, Inc. Common Stock seller in Q4 2019 was Fidelity Investments, an estimated $9.29M sold.

Based on aggregated 13F filings for Q4 2019.